Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
ETFs with MYL as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.73%||iShares NASDAQ Biotechnology Index Fund (IBB)||+59.67 (29.62%)|
|3.55%||iShares U.S. Pharmaceutical ETF (IHE)||+25.93 (24.55%)|
|1.75%||First Trust NASDAQ-100 Ex-Technology Sector Index Fund (QQXT)||+4.57 (14.25%)|
|1.36%||iShares Morningstar Mid Value Index Fund (JKI)||+11.86 (11.23%)|
|0.96%||Vanguard Mid-Cap Value ETF (VOE)||+8.49 (11.48%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Mylan Inc., along with its subsidiaries (collectively, the “Company,” “Mylan,” “our” or “we”), is a leading global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan is committed to setting new standards in health care and our mission is to provide the world’s 7 billion people access to high quality medicine. To do so, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. Mylan offers one of the industry’s broadest product portfolios, including more than 1,300 marketed products, to customers in approximately 140 countries and territories. ... More ...
|Annual EPS Est:||$2.89|
|Quarterly EPS Est:||0.66|